Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Somatostatin receptor scintigraphy (SRS) is positive in approximately 75% of all patients with neuroendocrine gastroenteropancreatic tumours. This study aimed to identify specific somatostatin receptor (sstr) subtypes, which are responsible for the in vivo binding of the widely used somatostatin ana...

詳細記述

保存先:
書誌詳細
主要な著者: John, M, Meyerhof, W, Richter, D, Waser, B, Schaer, J C, Scherübl, H, Boese-Landgraf, J, Neuhaus, P, Ziske, C, Mölling, K, Riecken, E O, Reubi, J C, Wiedenmann, B
フォーマット: Artigo
言語:Inglês
出版事項: 1996
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1382976/
https://ncbi.nlm.nih.gov/pubmed/8566856
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料